Treatment of oral hemangioma with 3% sodium tetradecyl sulfate: study of 20 cases

Hemangiomas possess an extremely challenging treatment dilemma for surgeons and the patients. Most of the hemangiomas involute but if they don't involutes or impair the vital functions or occur in adults they need intervention. Present study was conducted to evaluate and discuss the response of sclerosing agent 3% sodium tetradecyl sulfate (STDS) in oral hemangioma. All 20 cases of hemangioma were diagnosed clinically and were treated with 3% sodium tetradecyl sulfate (STDS) injections locally at regular intervals depending upon the size of the lesion. Hemangioma regressed in all the cases with considerable relief of symptoms with minimal complications. When used in appropriate doses, Sclerosing agent, 3% sodium tetradecyl sulfate (STD), is very effective for treatment of oral hemangioma.